What to check before you switch
Before moving any volume, confirm the platform layer change does not disrupt the pharmacy layer underneath. First, check formulary coverage: list your highest-volume SKUs — semaglutide, tirzepatide, your hormone and peptide lines — and confirm the 503A partners assigned to your Fizy Health clinic can fill them. Because both Belmar Pharma Solutions and Fizy Health are prescriber portals, not compounders, the actual medications come from LegitScript-certified 503A pharmacies, so coverage is the first thing to verify.
Second, review your existing Belmar Pharma Solutions agreement for any notice period, minimum commitment, or termination terms before you reduce volume — these are clinic-specific contract details you should read in your own agreement rather than assume. Third, decide what data you carry over: patient demographics, your common SIGs, and your repeat-order SKUs. None of this requires an EMR migration — prescriber portals live alongside your chart system, not in place of it.